.png){kind=icon}
返回
Systemic sclerosis-associated interstitial lung disease
.png){kind=icon}
PRE
AI
DOI：10.1016/S2213-2600(19)30480-1.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Systemic sclerosis is an autoimmune connective tissue disease, which is characterised by immune dysregulation and progressive fibrosis that typically affects the skin, with variable internal organ involvement. It is a rare condition that affects mostly young and middle-aged women, resulting in disproportionate morbidity and mortality. Currently, interstitial lung disease is the most common cause of death among patients with systemic sclerosis, with a prevalence of up to 30% and a 10-year mortality of up to 40%. Interstitial lung disease is more common among African Americans and in people with the diffuse cutaneous form of systemic sclerosis or anti-topoisomerase 1 antibodies. Systemic sclerosis-associated interstitial lung disease most commonly presents with dyspnoea, cough, and a non-specific interstitial pneumonia pattern on CT scan, with a minority of cases fulfilling the criteria for usual interstitial pneumonia. The standard therapy has traditionally been combinations of immunosuppressants, particularly mycophenolate mofetil or cyclophosphamide. These immunosuppressants can be supplemented by targeted biological and antifibrotic therapies, whereas autologous haematopoietic stem-cell transplantation and lung transplantation are reserved for refractory cases.
Keyword:
STEM-CELL TRANSPLANTATION
SURFACTANT PROTEIN D
RESOLUTION COMPUTED-TOMOGRAPHY
LONG-TERM PROGRESSION
SCLERODERMA LUNG
PULMONARY-FIBROSIS
ORAL CYCLOPHOSPHAMIDE
RISK PREDICTION
DOUBLE-BLIND
CT FEATURES
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
32.8
论文数:
3.2K
被引数:
2.3W
机构
引用论文
Dynamics of spin systems with randomly asymmetric bonds: Langevin dynamics and a spherical model
PREAI
分享收藏Evaluation of a commercial immunoassay for autoantibodies in Chinese Han systemic sclerosis population.png)
CLINICA CHIMICA ACTA
CLINICA CHIMICA ACTAIF2.9
PREAI
分享收藏Treatment of Scleroderma-Interstitial Lung Disease With Cyclophosphamide Is Associated With Less Progressive Fibrosis on Serial Thoracic High-Resolution CT Scan Than Placebo Findings From the Scleroderma Lung StudyCHEST
OAAI
CHESTIF8.6
OAAI分享收藏Clinically significant interstitial lung disease in limited scleroderma - Histopathology, clinical features, and survival局限性硬皮病中具有临床意义的间质性肺疾病-组织病理学，临床特征和生存率CHEST
CHESTIF8.6
PREAI
分享收藏
查看更多内容